Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Wistuba

Showing results (181-190 of 671) with videos related to

Pageof 68
Sort By:
The Journal of Molecular Diagnostics : JMD|February 23, 2019
Rational "Error Elimination" Approach to Evaluating Molecular Barcoded Next-Generation Sequencing Data Identifies Low-Frequency Mutations in Hematologic MalignanciesSaradhi Mallampati, Dzifa Y Duose, Michael A Harmon, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 11, 2017
Phase I Trial of Cediranib in Combination with Cisplatin and Pemetrexed in Chemonaive Patients with Unresectable Malignant Pleural Mesothelioma (SWOG S0905)Anne S Tsao, James Moon, Ignacio I Wistuba, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2008
Elevated phospho-S6 expression is associated with metastasis in adenocarcinoma of the lungJ Matthew McDonald, Christopher E Pelloski, Alicia Ledoux, et al.
Oncogene|September 17, 2013
miR-93-directed downregulation of DAB2 defines a novel oncogenic pathway in lung cancerL Du, Z Zhao, X Ma, et al.
Cancer Research|September 6, 2005
EGFR tyrosine kinase domain mutations are detected in histologically normal respiratory epithelium in lung cancer patientsXiming Tang, Hisayuki Shigematsu, B Nebiyou Bekele, et al.
The Journal of Thoracic and Cardiovascular Surgery|June 26, 2019
Tumor cellular proliferation is associated with enhanced immune checkpoint expression in stage I non-small cell lung cancerKyle G Mitchell, Edwin R Parra, David B Nelson, et al.
Cancer Research|April 23, 1999
Allelic losses at chromosome 8p21-23 are early and frequent events in the pathogenesis of lung cancerI I Wistuba, C Behrens, A K Virmani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 24, 2009
Expression of interleukin-1 receptor-associated kinase-1 in non-small cell lung carcinoma and preneoplastic lesionsCarmen Behrens, Lei Feng, Humam Kadara, et al.
Clinical Epigenetics|July 16, 2014
Impact of decitabine on immunohistochemistry expression of the putative tumor suppressor genes FHIT, WWOX, FUS1 and PTEN in clinical tumor samplesDavid J Stewart, Maria I Nunez, Jaroslav Jelinek, et al.
Cancer|November 2, 2006
Nuclear factor-kappaB (NF-kappaB) is frequently expressed in lung cancer and preneoplastic lesionsXiming Tang, Diane Liu, Shishir Shishodia, et al.
Pageof 68

Showing results (181-190 of 671) with videos related to

Sort By:
Pageof 68
The Journal of Molecular Diagnostics : JMD|February 23, 2019
Rational "Error Elimination" Approach to Evaluating Molecular Barcoded Next-Generation Sequencing Data Identifies Low-Frequency Mutations in Hematologic MalignanciesSaradhi Mallampati, Dzifa Y Duose, Michael A Harmon, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 11, 2017
Phase I Trial of Cediranib in Combination with Cisplatin and Pemetrexed in Chemonaive Patients with Unresectable Malignant Pleural Mesothelioma (SWOG S0905)Anne S Tsao, James Moon, Ignacio I Wistuba, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2008
Elevated phospho-S6 expression is associated with metastasis in adenocarcinoma of the lungJ Matthew McDonald, Christopher E Pelloski, Alicia Ledoux, et al.
Oncogene|September 17, 2013
miR-93-directed downregulation of DAB2 defines a novel oncogenic pathway in lung cancerL Du, Z Zhao, X Ma, et al.
Cancer Research|September 6, 2005
EGFR tyrosine kinase domain mutations are detected in histologically normal respiratory epithelium in lung cancer patientsXiming Tang, Hisayuki Shigematsu, B Nebiyou Bekele, et al.
The Journal of Thoracic and Cardiovascular Surgery|June 26, 2019
Tumor cellular proliferation is associated with enhanced immune checkpoint expression in stage I non-small cell lung cancerKyle G Mitchell, Edwin R Parra, David B Nelson, et al.
Cancer Research|April 23, 1999
Allelic losses at chromosome 8p21-23 are early and frequent events in the pathogenesis of lung cancerI I Wistuba, C Behrens, A K Virmani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 24, 2009
Expression of interleukin-1 receptor-associated kinase-1 in non-small cell lung carcinoma and preneoplastic lesionsCarmen Behrens, Lei Feng, Humam Kadara, et al.
Clinical Epigenetics|July 16, 2014
Impact of decitabine on immunohistochemistry expression of the putative tumor suppressor genes FHIT, WWOX, FUS1 and PTEN in clinical tumor samplesDavid J Stewart, Maria I Nunez, Jaroslav Jelinek, et al.
Cancer|November 2, 2006
Nuclear factor-kappaB (NF-kappaB) is frequently expressed in lung cancer and preneoplastic lesionsXiming Tang, Diane Liu, Shishir Shishodia, et al.
Pageof 68